col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: SCEEMP

16 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Safety and Risk of Pharmacotherapy 2022―Jul―19 Evaluation of the Rationality of Antibiotic Therapy of Nosocomial Infections in Resuscitation and Intensive Care Patients with COVID-19: a Retrospective Analysis K. I. Karnoukh, N. B. Lazareva
2 [GO] Safety and Risk of Pharmacotherapy 2022―Jul―04 Antibiotics for the treatment of COVID-19 Article Editorial
3 [GO] Safety and Risk of Pharmacotherapy 2022―Apr―11 Ivermectin: Evaluation of Efficacy and Safety in COVID-19 E. V. Shubnikova, N. A. Susekova, T. M. Bukatina, M. S. Galenko, A. A. Druzhinina
4 [GO] Safety and Risk of Pharmacotherapy 2022―Apr―11 Changes in Post-COVID Syndrome Manifestations and Bulbar Conjunctival Angioscopy Results in a Patient Undergoing Treatment after Mild COVID-19 V. V. Arkhipov, T. S. Kheilo, E. G. Gladysheva, Yu. A. Danilogorskaya, M. R. Dzhavatkhanova, S. V. Snytko, et al. (+2)
5 [GO] BIOpreparations Prevention Diagnosis Treatment 2021―Dec―22 Comparative analysis of existing platforms for the development of vaccines against dangerous and extremely dangerous viral infections with pandemic potential G. G. Onishchenko, T. E. Sizikova, V. N. Lebedev, S. V. Borisevich
6 [GO] Safety and Risk of Pharmacotherapy 2021―Dec―21 Experience in Using Antiviral Agents for the Treatment of Novel Coronavirus Infection (COVID-19) in Kyrgyzstan A. A. Zurdinova, A. Z. Kutmanova
7 [GO] BIOpreparations Prevention Diagnosis Treatment 2021―Oct―04 Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest® SARS-CoV-2 ELISPOT kit D. A. Poteryaev, S. G. Abbasova, P. E. Ignatyeva, O. M. Strizhakova, S. V. Kolesnik, R. A. Khamitov
8 [GO] BIOpreparations Prevention Diagnosis Treatment 2021―Oct―04 Comparative characteristics of COVID-19 vaccines used for mass immunisation G. G. Onishchenko, T. E. Sizikova, V. N. Lebedev, S. V. Borisevich
9 [GO] The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 2021―Mar―10 Planning Bioequivalence Studies in the Context of the COVID-19 Pandemic D. P. Romodanovsky, A. L. Khokhlov, D. V. Goryachev
10 [GO] BIOpreparations Prevention Diagnosis Treatment 2020―Dec―15 Analysis of Promising Approaches to COVID-19 Vaccine Development G. G. Onishchenko, T. E. Sizikova, V. N. Lebedev, S. V. Borisevich
11 [GO] BIOpreparations Prevention Diagnosis Treatment 2020―Dec―15 Russian and International Regulatory Recommendations for the Development and Marketing Authorisation of COVID-19 Vaccines in the Context of the Pandemic A. A. Soldatov, Zh. I. Avdeeva, V. P. Bondarev, V. A. Merkulov, V. D. Mosyagin, V. B. Ivanov, et al. (+2)
12 [GO] BIOpreparations Prevention Diagnosis Treatment 2020―Sep―18 Prospects for Using the ELISPOT Technological Platform as Part of Anti-Epidemic Measures Against the New Coronavirus Infection COVID-19 D. A. Poteryaev, R. A. Khamitov, G. A. Efimov, A. M. Shuster
13 [GO] The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 2020―Sep―18 Safety of Hydroxychloroquine, Favipiravir, and the Combination of Lopinavir and Ritonavir in the Treatment of the “First Wave” of the New Coronavirus Infection COVID-19 B. K. Romanov
14 [GO] Safety and Risk of Pharmacotherapy 2020―Sep―18 Safety of Remdesivir and Tocilizumab in COVID-19 Treatment Article Editorial
15 [GO] Safety and Risk of Pharmacotherapy 2020―Mar―28 Coronavirus disease COVID-2019 B. K. Romanov
16 [GO] BIOpreparations Prevention Diagnosis Treatment 2020―Mar―26 An Outbreak of a New Infectious Disease COVID-19: β-coronaviruses as a Threat to Global Healthcare D. V. Gorenkov, L. M. Khantimirova, V. A. Shevtsov, A. V. Rukavishnikov, V. A. Merkulov, Yu. V. Olefir
 [1] 

16 Results       Page 1




[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.007 sec